Circumstances that Constitute Delaying, Denying, Limiting, or Refusing a Drug or Device Inspection: Guidance for Industry

Information

Type

Guidance

Regulated products

Animal & Veterinary, Biologics, Drugs, Medical Devices

Topics

Postmarket

Published

June 20, 2024

Last updated

June 21, 2024

Description

Guidance document for the industry outlining circumstances constituting delays in drug or device inspections, focusing on postmarket topics.

Organization

Country / Region

United States

License

Other (Public Domain)

Feedback

Suggest an improvement to this page

Actions

Social networks

Embed